Drug
Pioglitazone
Pioglitazone: highest development phase Post-Market, developed by Takeda, Viatris. 2 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Takeda, Viatris
Trials
| Drug | Phase | Indication |
|---|---|---|
| Pioglitazone NCT00402012 | Post-Market | Diabetes Mellitus, Type 2 |
| Pioglitazone HCl Tablets 45 mg NCT00649012 | Phase 1 | Healthy |
Latest
No recent events.
Follow Pioglitazone on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.